Detalhe da pesquisa
1.
Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC.
J Thorac Oncol
; 14(12): 2071-2083, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31449889
2.
Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells.
Cancer Immunol Res
; 4(12): 1049-1060, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27799141